Tag: A2B530 CAR-T orphan drug

Home / A2B530 CAR-T orphan drug

Categories

Orphan drug designation is given by FDA to CART T-Cell Therapy A2B530 for the treatment of colorectal cancer

In March 2024, a news release said that A2B530 (A2 Biotherapeutics), a CAR T-cell therapy, had been given Orphan Drug Designation to treat colorectal cancer that expresses carcinoembryonic antigen (C...
a2b530-car-t-orphan-drug

Scan the code